SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

1999883 citationsJournal Article

Authors

Carl G. Groth · Stockholm University College of Music Education

Lars Bäckman

Abstract

Results at 12 months suggest that sirolimus can be used as base therapy in the prophylaxis of acute renal transplant rejection, and has a safety profile that differs from CsA.

Topics & Keywords

Renal Transplantation Outcomes and Treatments Oral and gingival health research Neurological Complications and Syndromes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 67, Issue 7, pp. 1036-1042

DOI: 10.1097/00007890-199904150-00017

Field-Weighted Citation Impact: 38.61